They inhibit the anti-tumor immune responses through multiple mechanisms including the depletion of key amino acids (e.g., tryptophan, L-arginine), production of inhibitory factors (IL-10, TGF-β) that suppress T cell effector functions and recruitment of regulatory T cells to the TME [8,9]. Here, TGFB1 is linked to neoplasm.